**Core tip:** To date, 32 cases of paraneoplastic pemphigus (PNP)-associated follicular dendritic cell (FDC) sarcomas have been reported in the English literature. Inflammatory pseudotumor-like FDC sarcoma was described as an underlying neoplasm of PNP in only two cases. Here, we report a case that PNP was the patient's first symptom of an intra-abdominal inflammatory pseudotumor-like FDC sarcoma, and review the related literature.

INTRODUCTION
============

Follicular dendritic cell (FDC) sarcoma was first described in 1986 by Monda et al\[[@B1]\] as a nonlymphomatous lymph node malignancy with features suggesting a FDC origin. It is classified into two types: (1) Conventional FDC sarcomas that are histologically characterized by spindle cell proliferation with fascicles, trabecular, or diffuse sheets; and (2) Inflammatory pseudotumor (IPT)-like FDC sarcomas, an entity proposed by Cheuk et al\[[@B2]\] in 2001, which are characterized by dispersed spindle or ovoid tumor cells against a background of abundant lymphocytes and plasma cells. However, in contrast to conventional FDC sarcomas, IPT-like FDC sarcomas predominantly arise in intra-abdominal sites, especially the liver and spleen. Paraneoplastic pemphigus (PNP), which was first described in 1990, is a rare and life-threatening mucocutaneous autoimmune disease that is associated with underlying neoplasms, especially lymphoproliferative disorders\[[@B3]\]. A total of 32 cases of FDC sarcomas associated with the occurrence of PNP have been previously reported (Table [1](#T1){ref-type="table"})\[[@B4]-[@B30]\]. Only two case wherein an IPT-like FDC sarcoma is an underlying neoplasm of PNP have been described\[[@B20],[@B31]\]. Here, we report a 27-year-old woman who presented stomatitis, conjunctivitis, and polymorphic cutaneous lesions, which are consistent with the features of PNP, as her first symptoms of intra-abdominal IPT-like FDC sarcoma, and review the related literature. This work intends to serve as a reference for the correct identification of this disease by clinicians. It also aims to broaden clinicians' understanding of this kind of tumor, PNP, and their rare relationship.

###### 

Summary of 32 cases of paraneoplastic pemphigus-associated follicular dendritic cell sarcoma

  **Ref**.                      **Sex/age**   **Tumor pathology**       **Location**                             **Maximum diameter (cm)**   **Clinical manifestations**                                                                   **Treatments**                                                                                                          **Follow-up**
  ----------------------------- ------------- ------------------------- ---------------------------------------- --------------------------- --------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------
  Walters et al\[[@B4]\]        M/48          FDCS                      Anterior mediastinum                     NA                          Lichenoid skin lesions, BO, MG                                                                Tumor resection, multiple immunosuppressive therapies                                                                   Progressive respiratory disease
                                M/88          FDCS                      Retropharynx                             8                           Mucosal lichenoid erosions                                                                    Tumor resection                                                                                                         DOD within 1 yr, status unknown
                                F/59          FDCS                      Axillary lymph node                      NA                          Lichenoid skin lesions, mucocutaneous blisters, BO                                            Tumor resection                                                                                                         DOD within 6 mo
                                M/23          FDCS associated with CD   Cervical lymph node                      NA                          Mucosal lichenoid erosions, BO                                                                Partial tumor resection and residual mass was radiated                                                                  Tumor recurrence and DOD within 2 yr
  Lu et al\[[@B5]\]             F/49          FDCS                      Pancreatic tail                          6                           Stomatitis, MG, pulmonary infection                                                           Tumor resection, antifungal and anti-infection therapies                                                                DOD 12 d after surgery
  Jonkman et al\[[@B6]\]        F/35          FDCS                      Intra-abdomen                            NA                          Stomatitis, punctate keratoses with central ulceration on the palms and soles.                Tumor resection and intensive immunosuppression                                                                         DOD with respiratory failure
  Akel et al\[[@B7]\]           M/39          FDCS                      Intra-abdomen                            18                          Lichenoid skin lesions, mucocutaneous blisters, febrile neutropenia                           Tumor resection and high-dose steroids                                                                                  DOD with severe pneumonia and acidosis
  Wang et al\[[@B8]\]           F/56          FDCS associated with CD   Retroperitoneum                          10                          Stomatitis, polymorphous skin lesions, BO                                                     Tumor resection, IVIg and steroid therapies                                                                             Alive at 4 yr follow-up
  Wang et al\[[@B9]\]           F/27          FDCS                      Retroperitoneum                          8                           Stomatitis, conjunctivitis, lichenoid skin lesions                                            Tumor resection                                                                                                         Tumor recurrence 5 yr after surgery
  Su et al\[[@B10]\]            M/43          FDCS                      Retroperitoneum                          5                           Stomatitis, lichenoid skin lesions                                                            Tumor resection and lymphadenectomy, IVIg and steroid therapies                                                         DOD with multiple organ failure
  Chow et al\[[@B11]\]          M/62          FDCS                      Anterior mediastinum                     7.5                         Stomatitis, conjunctivitis, mucocutaneous blisters                                            Right thoracotomy and tumor resection, adjuvant radiotherapy                                                            DOD with respiratory failure
  Garza-Chapa et al\[[@B12]\]   M/20          FDCS                      Right-side mediastinum                   7                           Stomatitis, conjunctivitis, lichenoid skin lesions                                            Right thoracotomy and tumor resection, chemotherapy with R-CVP (rituximab, cyclophosphamide, vincristine, prednisone)   Resolution of skin lesions and no evidence of tumor recurrence at 1-yr follow-up
  Streifel et al\[[@B13]\]      M/72          FDCS                      Right-side mediastinum                   NA                          Stomatitis, conjunctivitis, and glans penis involvement, lichenoid skin lesions, MG           Thymectomy and partial pericardiectomy, rituximab, IVIg, steroids and mycophenolate mofetil                             Improvement at 9-mo follow-up
  Kim et al\[[@B14]\]           M/68          FDCS                      Small bowel mesentery                    9                           Abdominal palpable mass, stomatitis, conjunctivitis, MG                                       Tumor resection                                                                                                         Metastatic tumors found in the liver 1 yr after surgery; DOD within 2 yr
  Seishima et al\[[@B15]\]      F/64          FDCS                      Retroperitoneum and small intestine      15                          Stomatitis, conjunctivitis, severe skin erosions                                              Tumor resection and steroid therapy                                                                                     Tumor recurrence; DOD with fungal infective embolisms in the lungs
  Liu et al\[[@B16]\]           F/54          FDCS                      Retroperitoneum                          10.8                        Stomatitis, Lichenoid skin lesions                                                            Tumor resection, systemic corticosteroid, and cyclosporine therapies                                                    DOD with respiratory failure
  Baghmar et al\[[@B17]\]       M/20          FDCS                      Right hemipelvis                         6                           Stomatitis, conjunctivitis, lichenoid skin lesions                                            Unresectable, chemotherapy with rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone                  DOD with respiratory pseudomonas infections
  Hwang et al\[[@B18]\]         F/46          FDCS                      Liver                                    16                          Abdominal pain, Stomatitis, lichenoid skin lesions                                            Tumor resection, rituximab and ciclosporin therapies                                                                    Tumor recurrence 1 yr after surgery; DOD with pneumonia
  Lee et al\[[@B19]\]           M/67          FDCS associated with CD   Small bowel mesentery                    NA                          Stomatitis, conjunctivitis, MG                                                                Tumor resection, IVIg, prednisolone, and cyclosporine therapies                                                         Metastatic tumors found in the liver 1 yr after surgery
  Zhao et al\[[@B20]\]          F/28          IPT-like FDCS             Intra-abdomen                            9                           Stomatitis, blisters and erosions of the underarm, groin and perineum, and labia majora, BO   Tumor resection                                                                                                         Improvement after surgery
  Sugiura et al\[[@B21]\]       M/28          FDCS associated with CD   Left retroperitoneum                     7.7                         Stomatitis, polymorphic cutaneous lesions, papillomatous hyperplasia on the tongue            Tumor resection, chemotherapy of COP (cyclophosphamide, vincristine, and prednisolone)                                  Skin lesions healed completely except for the papillomatous hyperplasia on the tongue, and follow-up is not clear
  Marzano et al\[[@B22]\]       F/53          FDCS                      Right retroperitoneum                    9                           Stomatitis, conjunctivitis, lichenoid skin lesions, dyspnea                                   Tumor resection, systemic corticosteroid and IVIg therapies                                                             DOD with respiratory failure within 2 yr
  Meijs et al\[[@B23]\]         M/60          FDCS                      Mediastinum                              6                           Stomatitis, conjunctivitis, mucocutaneous blisters and erosions, BO                           Tumor resection, chemotherapy with rituximab, IVIg, plasmapheresis, corticosteroid, azathioprine and cyclophosphamide   DOD with respiratory failure
  Lee et al\[[@B24]\]           M/66          FDCS associated with CD   Right retroperitoneum                    12                          Stomatitis, conjunctivitis, mucocutaneous blisters and erosions, lichenoid skin lesions       Tumor resection and antibiotics therapy                                                                                 DOD with sepsis 8 d after surgery
  Choi et al\[[@B25]\]          F/39          FDCS                      NA                                       NA                          Stomatitis, mucocutaneous blisters and erosions                                               Tumor resection                                                                                                         Alive for 5 yr, and skin lesions healed except for oral persistent mucositis
  Zhang et al\[[@B26]\]         M/20          FDCS associated with CD   NA                                       NA                          Stomatitis, conjunctivitis and genital involvement, skin blisters                             Tumor resection                                                                                                         Alive for 3 yr without recurrence
                                M/16          FDCS associated with CD   NA                                       NA                          Stomatitis, conjunctivitis and genital involvement, skin blisters                             Tumor resection                                                                                                         DOD with severe infections 2 wk after surgery
  Yamada et al\[[@B27]\]        M/68          FDCS                      Retroperitoneum                          NA                          Stomatitis, conjunctivitis and genital involvement, polymorphic cutaneous lesions             Tumor resection, plasmapheresis, and steroid pulse therapies                                                            DOD with septicemia 2 mo after surgery
  Ogawa et al\[[@B28]\]         M/28          FDCS                      Retroperitoneum                          NA                          Stomatitis, skin blisters and erosions                                                        Partial resection, IVIg, chemotherapy with cyclophosphamide, vincristine, and prednisolone therapies                    Alive for 3 yr, and skin lesions healed except for oral persistent mucositis
  Raco et al\[[@B29]\]          F/61          FDCS associated with CD   Intra-abdomen                            10                          Stomatitis, lichenoid skin lesions, dyspnea                                                   Previous: splenectomy and chemotherapy 3 yr agoRecent: IVIg, rituximab, steroid and antibiotic therapies                Tumor metastasis or recurrence; DOD with respiratory failure
  Rice et al\[[@B30]\]          F/41          FDCS                      Retroperitoneum                          8                           Stomatitis, conjunctivitis, lichenoid skin lesions dyspnea,                                   Tumor resection, IVIg, systemic corticosteroid, rituximab, and daclizumab therapies                                     Progressive respiratory failure
  Wang et al\[[@B31]\]          F/60          IPT-like FDCS             Left axillary and cervical lymph nodes   6.4                         Stomatitis, polymorphic cutaneous lesions, MG, dyspnea                                        Tumor resection, IVIg, steroid, and rituximab therapies                                                                 DOD with multiple organ failure
  Present case                  F/27          IPT-like FDCS             Intra-abdomen                            9                           Stomatitis, conjunctivitis, skin blisters and erosions, mild dyspnea                          Tumor resection, tapering corticosteroid                                                                                No evidence of tumor recurrence at 1-yr follow-up

M: Male; F: Female; DOD: Dead of disease; NA: Not available; FDCS: Follicular dendritic cell sarcoma; CD: Castleman disease; BO: Bronchiolitis obliterans; MG: Myasthenia gravis; IVIg: Intravenous immunoglobulin.

CASE PRESENTATION
=================

Chief complaints
----------------

A 27-year-old Chinese woman presented with complaints of painful desquamative stomatitis, conjunctivitis for 2 mo (Figure [1A](#F1){ref-type="fig"}), and polymorphic skin lesions on the trunk (Figure [1B](#F1){ref-type="fig"}) for half a month.

![Diffuse lips and mucosal erythema and erosions (A), erythema and loose blisters on the trunk (B), intraepidermal acantholysis and blisters (orange arrow; HE × 40) (C), and linear deposition of C3 in the basal stratum of skin (orange arrow; × 100) (D).](WJCC-8-3097-g001){#F1}

History of present illness
--------------------------

Oral blisters and erosions occurred first, and skin lesions, including erythema, vesicles, and erosions, developed on the trunk subsequently. The patient had no abdominal discomfort or other gastrointestinal symptoms.

Physical examination upon admission
-----------------------------------

Oral blisters and erosions involved mucus membranes, the tongue, and lips. The vesicles on the trunk were loose and positive for the Nikolsky sign (a dermatological examination method of acanthocyte loosening that is performed to check whether blisters and bullae are located inside or under the epidermis).

Laboratory examinations
-----------------------

Enzyme-linked immunosorbent assay revealed increased concentrations of circulating serum autoantibodies against desmoglein-1 and desmoglein-3 (two kinds of pemphigus antibodies).

Imaging examinations
--------------------

For the patient complained of mild dyspnea, a chest computed tomography (CT) scan was performed, which revealed mild bronchiolitis obliterans on the patient's lungs. Besides, it happened to scan an iso-dense, well-circumscribed mass in the upper abdominal area (Figure [2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}).

![Computed tomography scan showed that there was an iso-dense, well-circumscribed mass (orange arrow) in the upper abdominal area. A: Axial section; B: Coronal section.](WJCC-8-3097-g002){#F2}

Histological examinations
-------------------------

Skin lesion biopsy showed intraepidermal acantholysis and blisters (Figure [1C](#F1){ref-type="fig"}). Moreover, C3 was detected in the basal stratum through direct immunofluorescence (Figure [1D](#F1){ref-type="fig"}). The postoperative pathology of the tumor showed that spindle vacuolar tumor cells with mild cellular atypia were distributed against a background of abundant small lymphocytes, especially in pseudofollicles (Figure [3A](#F3){ref-type="fig"}). Some abnormal nuclear fissions were observed (Figure [3B](#F3){ref-type="fig"}), and cells resembling Reed--Sternberg cells were captured at times. Immunohistochemical studies revealed that the tumor cells were positive for CD21 (Figure [3C](#F3){ref-type="fig"}), CD68, and Ki-67 (maximally 20% to 30%) and negative for CK, CD3, HMB-45, CD20, CD30, CD34, CD117 (Figure [3D](#F3){ref-type="fig"}), and anaplastic lymphoma kinase.

![The tumor tissue had a clear boundary (HE × 20) (A), spindle tumour cells were distributed in the background of abundant small lymphocytes (HE × 100) (B), the neoplastic cells were strong positive for CD21 (× 200) (C), and the neoplastic cells were negative for CD117 (× 100) (D).](WJCC-8-3097-g003){#F3}

FINAL DIAGNOSIS
===============

PNP associated with IPT-like FDC sarcoma.

TREATMENT
=========

Before the diagnosis of IPT-like FDC sarcoma, the patient received treatments of methylprednisolone combined with cyclophosphamide and showed improvement but shortly relapsed. After the diagnosis of IPT-like FDC sarcoma, the patient underwent surgical resection of the sarcoma. The resected tumor, which had dimensions of 9 cm × 6 cm × 6 cm, was solid and circumscribed. Gradually tapering methylprednisolone treatment was continued as a conservative adjuvant therapy to ensure that the patient's PNP was controlled.

OUTCOME AND FOLLOW-UP
=====================

When the patient previously received drug treatments for pemphigus, she improved but her symptoms relapsed shortly. By contrast, after the surgical resection of her sarcoma, the patient was free from pemphigus symptoms. PNP and IPT-like FDC sarcoma showed no recurrence at the 1-year follow-up (Figure [4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}).

![Mucosal and skin lesions had disappeared, leaving lichenoid hyperpigmentation behind (A and B).](WJCC-8-3097-g004){#F4}

DISCUSSION
==========

In the case that we described, the existence and disappearance of PNP had a direct relationship with IPT-like FDC sarcoma. This relationship adequately illustrated an extremely unusual association of IPT-like FDC sarcoma with PNP. Sarcoma is an underlying malignancy in approximately 6% of PNP cases; it is involved in leiomyosarcomas, liposarcomas, malignant nerve sheath tumors, poorly differentiated sarcomas, reticulum cell sarcomas, dendritic cell sarcomas, and inflammatory myofibroblastic tumors\[[@B32]\]. The occurrence of PNP with IPT-like FDC sarcoma is rare. To date, 32 cases of PNP-associated FDC sarcomas have been reported in the English literature (Table [1](#T1){ref-type="table"}). Given that IPT-like FDC sarcoma was described as an underlying neoplasm of PNP in only two cases\[[@B20],[@B31]\], our presentation is extremely rare. PNP-associated FDC sarcomas tend to show an Asian preference (21/32), especially among Eastern Asians. Previously reported cases involved 18 males and 14 females (male/female ratio of 1.3: 1) with a mean age of 47 years (range, 16-88 years). The locations of FDC sarcomas were the mediastinum (5/29), cervix (3/29), axillary lymph nodes (2/29), and intra-abdominal sites (20/29). Locations were not mentioned in three cases. Nearly 70% cases of PNP-associated FDC sarcomas occurred in intra-abdominal sites, even though FDC sarcomas themselves predominantly occur in the cervical and axillary lymph nodes. This characteristic suggests that intra-abdominal FDC sarcomas may indicate a poor prognosis. Furthermore, in six cases, FDC sarcomas caused PNP were coexisting with myasthenia gravis (MG)\[[@B4],[@B5],[@B13],[@B14],[@B19],[@B21]\]. Paraneoplastic neurologic syndromes are even rarer than other syndromes, occurring in approximately 0.01% of patients with cancer\[[@B33]\]. PNP was the first autoimmune disease that was demonstrated to be associated with FDC sarcoma\[[@B24]\]. Subsequently, Hartert et al\[[@B34]\] first reported in 2010 that FDC sarcoma is associated with MG without PNP. What's more, Sandri et al\[[@B35]\] once reported that paraneoplastic arthritis is the first symptom of IPT-like FDC sarcoma. FDC sarcoma is one of the underlying risk factors for developing paraneoplastic autoimmune diseases, which show a high mortality rate. Its early and correct identification by clinicians is crucial.

Previous reports have revealed that diseases associated with PNP predominantly underlie B-cell lymphoproliferative diseases, for example, non-Hodgkin lymphomas, chronic lymphocytic leukemia, and Castleman disease, such that 84% of neoplasms are associated with PNP\[[@B31]\]. Interestingly, we found that Castleman disease was involved in eight cases of PNP-associated FDC sarcoma (Table [1](#T1){ref-type="table"})\[[@B4],[@B8],[@B19],[@B21],[@B24],[@B26],[@B29]\]. In China, PNP is frequently found in association with Castleman's tumors\[[@B36]\]. Some researchers assumed that FDC sarcoma arose from hyaline vascular Castleman disease, possibly through a mechanism involving epidermal growth factor receptors\[[@B37]\]. A recent genetic study has suggested that FDC sarcomas associated with unicentric hyaline-vascular Castleman disease show mutations and copy number changes in known oncogenes, tumor suppressors, and chromatin remodeling genes\[[@B38]\]. In addition, histologically, indolent T-lymphoblastic proliferation is frequently found in FDC sarcomas and shows an association with paraneoplastic autoimmune multiorgan syndrome; this association suggests that neoplastic follicular dendritic cells can recruit or foster the proliferation of immature T cells, which may lead to the occurrence of PNP\[[@B4],[@B22]\]. In the present study, we failed to detect the immunohistochemistry of TdT, which is a necessary index for later studies. However, the patient's manifestations improved and her serum autoantibody titers gradually decreased after tumor resection. We thus hypothesized that B lymphocytes also have a notable role in this associated tumor. Zhu's research team used a specific peptide to probe the specific immunoglobulin receptors on tumor B lymphocytes from patients with PNP and confirmed that associated tumors can produce autoantibodies against antigens in the epidermis\[[@B39]\]. The relationships among immature T cells--B cells--PNP in FDC sarcomas and other trigger tumors require further studies.

FDC sarcomas are low-grade tumors. Further studies with long follow-up periods have recently indicated that FDC sarcomas are at least intermediate-grade tumors given their local recurrence and occasional distant metastases\[[@B40]\]. PNP-associated FDC sarcomas suggest a poor prognosis and high mortality rate. The risk factors related to mortality are severe infections, such as sepsis and infectious pneumonia; lung bronchiolitis obliterans; multiple organ dysfunction; and tumor recurrences or metastases (Table [1](#T1){ref-type="table"}). The stabilization of vital parameters, the evaluation of any underlying malignancy, the accurate diagnosis of PNP, the removal and medical therapy of the trigger tumor, and the treatment of PNP are six indispensable steps to improve the management of patients with PNP\[[@B41]\]. We reckoned that the early treatment and management of PNP helped prevent serious infection and degeneration in the present case. However, PNP, especially stubborn oral mucosa lesions that are observed in most cases, is considered refractory to conventional medical treatments compared with other types of pemphigus. Unified criteria for the therapy and evidence-based treatment of PNP remain lacking. The early detection and resection of trigger tumors are essential for the treatment of PNP since they may produce autoantibodies to impair the epidermis\[[@B39]\]. The 31 patients that we reviewed above underwent complete (29/31) or partial (2/31) surgical resection. Only one case had a tumor that was found to be unresectable during exploratory laparotomy\[[@B17]\]. Surgical resection seems to be the first choice for the treatment of primary and recurrent FDC sarcomas, whereas the role of adjuvant radiotherapy or chemotherapy has not been well defined\[[@B42]\]. A recent study revealed that the local recurrence and distant metastasis rate of IPT-like FDC sarcomas is approximately 17%\[[@B43]\], whereas that of conventional FDC sarcomas is 40%--50%, suggesting that IPT-like FDC sarcomas are a more indolent variant of FDC sarcomas. Our patient showed no recurrence or metastasis of the sarcoma at the 1-year follow-up. Continued long-term follow is required to obtain improved insight into these two diseases.

CONCLUSION
==========

IPT-like FDC sarcomas are rare underlying neoplasms that have an uncommon association with PNP. To date, only 32 cases of PNP-associated FDC sarcomas have been reported in the English literature. Intra-abdominal FDC sarcomas may suggest a poor prognosis. The immature T cells and B cells of FCD sarcomas might play roles in PNP development, and the mechanisms of these roles require further studies. Surgical resection is an essential and effective treatment for PNP and primary and recurrent FDC sarcomas. IPT-like FDC sarcomas seem to be more indolent than conventional FDC sarcomas, and long-term follow-up is required.
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